Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma

被引:2
|
作者
Huang, Tingting [1 ]
Tian, Wei [1 ]
Zhou, Qingqing [1 ]
Li, Jiajun [1 ]
Jiang, Zhiyuan [1 ]
Chen, Jinsi [1 ]
Ge, Chao [1 ]
Tian, Hua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Rpn10; prognosis; NE-kappa B; clear cell renal cell carcinoma; HEPATOCELLULAR-CARCINOMA; PROTEASOME; CANCER; MIGRATION;
D O I
10.1093/abbs/gmab078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proliferation, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NE-kappa B) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (I kappa B alpha) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of I kappa B alpha in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NE-kappa B pathways and is a prognostic indicator for patients with ccRCC.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 50 条
  • [41] EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
    Xu, Z. Q.
    Zhang, L.
    Gao, B. S.
    Wan, Y. G.
    Zhang, X. H.
    Chen, B.
    Wang, Y. T.
    Sun, N.
    Fu, Y. W.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (01): : 41 - 49
  • [42] HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway
    Yao, Sheng
    He, Longjun
    Zhang, Yi
    Ye, Liping
    Lai, Yingrong
    Huang, Linlin
    Wu, Ling
    Wu, Guojun
    Zhu, Senlin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 501 (03) : 628 - 635
  • [43] UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation
    Long, Li
    Wang, Lei
    Liang, Yiran
    Ye, Fangzhou
    Jin, Yuhan
    Luo, Dan
    Li, Xiaoyan
    Wang, Yajie
    Li, Yaming
    Han, Dianwen
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Yang, Qifeng
    TRANSLATIONAL ONCOLOGY, 2025, 52
  • [44] Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway
    Nomoto, Daichi
    Baba, Yoshifumi
    Liu, Yang
    Tsutsuki, Hiroyasu
    Okadome, Kazuo
    Harada, Kazuto
    Ishimoto, Takatsugu
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Miyamoto, Yuji
    Yoshida, Naoya
    Watanabe, Masayuki
    Moroishi, Toshiro
    Komohara, Yoshihiro
    Sawa, Tomohiro
    Baba, Hideo
    CANCER LETTERS, 2022, 530 : 59 - 67
  • [45] Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma
    Zhou Jiangqiao
    Qiu Tao
    Chen Zhongbao
    Ma Xiaoxiong
    Zhang Long
    Zou Jilin
    Wang Tianyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (01) : 165 - 172
  • [46] RELT promotes the growth of esophageal squamous cell carcinoma by activating the NF-κB pathway
    Yao, Wenjian
    Chen, Qing
    Li, Saisai
    Jia, Xiangbo
    Xu, Lei
    Wei, Li
    CELL CYCLE, 2021, 20 (13) : 1231 - 1241
  • [47] FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
    Jiang, Kun
    Xu, Li-zhe
    Ning, Jin-zhuo
    Cheng, Fan
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [48] SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway
    He-Xi Wang
    Zhi-Peng Zhao
    Xiao-Yi Du
    Sen-Lin Peng
    Hao-Yu Xu
    Wei Tang
    Lei Yang
    Medical Oncology, 41
  • [49] SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway
    Wang, He-Xi
    Zhao, Zhi-Peng
    Du, Xiao-Yi
    Peng, Sen-Lin
    Xu, Hao-Yu
    Tang, Wei
    Yang, Lei
    MEDICAL ONCOLOGY, 2024, 41 (02)
  • [50] FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
    Kun Jiang
    Li-zhe Xu
    Jin-zhuo Ning
    Fan Cheng
    Cancer Cell International, 23